Wang Min - Net Worth and Insider Trading
Wang Min Net Worth
The estimated net worth of Wang Min is at least $730,800 dollars as of 2024-11-13. Wang Min is the senior management of Kangmei Pharmaceutical Co Ltd and owns about 290,000 shares of Kangmei Pharmaceutical Co Ltd (SHSE:600518) stock worth over $730,800. Details can be seen in Wang Min's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Wang Min has not made any transactions after 2015-07-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Wang Min
Wang Min Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Wang Min owns 1 companies in total, including Kangmei Pharmaceutical Co Ltd (SHSE:600518) .
Click here to see the complete history of Wang Min’s form 4 insider trades.
Insider Ownership Summary of Wang Min
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SHSE:600518 | Kangmei Pharmaceutical Co Ltd | 2015-07-21 | senior management |
Wang Min Latest Holdings Summary
Wang Min currently owns a total of 1 stock. Wang Min owns 290,000 shares of Kangmei Pharmaceutical Co Ltd (SHSE:600518) as of July 21, 2015, with a value of $730,800.
Latest Holdings of Wang Min
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SHSE:600518 | Kangmei Pharmaceutical Co Ltd | 2015-07-21 | 290,000 | 2.52 | 730,800 |
Holding Weightings of Wang Min
Wang Min Form 4 Trading Tracker
According to the SEC Form 4 filings, Wang Min has made a total of 0 transactions in Kangmei Pharmaceutical Co Ltd (SHSE:600518) over the past 5 years. The most-recent trade in Kangmei Pharmaceutical Co Ltd is the acquisition of 30,000 shares on July 21, 2015, which cost Wang Min around $576,000.
Insider Trading History of Wang Min
- 1
Wang Min Trading Performance
GuruFocus tracks the stock performance after each of Wang Min's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Wang Min is 4.85%. GuruFocus also compares Wang Min's trading performance to market benchmark return within the same time period. The performance of stocks bought by Wang Min within 3 months outperforms 2 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Wang Min's insider trading performs compared to the benchmark.
Wang Min Ownership Network
Ownership Network List of Wang Min
Ownership Network Relation of Wang Min
Wang Min Owned Company Details
What does Kangmei Pharmaceutical Co Ltd do?
Who are the key executives at Kangmei Pharmaceutical Co Ltd?
Wang Min is the senior management of Kangmei Pharmaceutical Co Ltd. Other key executives at Kangmei Pharmaceutical Co Ltd include senior management Li Jian Hua , senior management Peng Qin , and senior management Lin Guo Xiong .
Kangmei Pharmaceutical Co Ltd (SHSE:600518) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Kangmei Pharmaceutical Co Ltd (SHSE:600518) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kangmei Pharmaceutical Co Ltd (SHSE:600518) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Kangmei Pharmaceutical Co Ltd (SHSE:600518)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kangmei Pharmaceutical Co Ltd Insider Transactions
Wang Min Mailing Address
Above is the net worth, insider trading, and ownership report for Wang Min. Currently GuruFocus does not have mailing address information for Wang Min.